Toxicological Research

Korean Society of Toxicology & Korea Environmental Mutagen Society (한국독성학회)
권호 표지
DOI QR코드

DOI QR Code

Risk Assessment of Triclosan, a Cosmetic Preservative

  • Received : 2019.02.21
  • Accepted : 2019.03.10
  • Published : 2019.04.15
Download PDF
⟨ Previous Next ⟩

Abstract

Triclosan (TCS) is an antimicrobial compound used in consumer products. The purpose of current study was to examine toxicology and risk assessment of TCS based on available data. Acute toxicities of oral, transdermal and inhalation routes were low, and phototoxicity and neurotoxicity were not observed. Topical treatment of TCS to animal caused mild irritation. TCS did not induce reproductive and developmental toxicity in rodents. In addition, genotoxicity was not considered based on in vitro and in vivo tests of TCS. It is not classified as a carcinogen in international authorities such as International Agency for Research on Cancer (IARC). No-observed-adverse-effect level (NOAEL) was determined 12 mg/kg bw/day for TCS, based on haematoxicity and reduction of absolute and relative spleen weights in a 104-week oral toxicity study in rats. Percutaneous absorption rate was set as 14%, which was human skin absorption study reported by National Industrial Chemicals Notification and Assessment Scheme (NICNAS) (2009). The systemic exposure dosage (SED) of TCS has been derived by two scenarios depending on the cosmetics usage of Koreans. The first scenario is the combined use of representative cosmetics and oral care products. The second scenario is the combined use of rinse-off products of cleansing, deodorants, coloring products, and oral care products. SEDs have been calculated as 0.14337 mg/kg bw/day for the first scenario and 0.04733 mg/kg bw/day for the second scenario. As a result, margin of safety (MOS) for the first and second scenarios was estimated to 84 and 253.5, respectively. Based on these results, exposure of TCS contained in rinse-off products, deodorants, and coloring products would not pose a significant health risk when it is used up to 0.3%.

Keywords

References

  1. US FDA (Food and Drug Administration) (2008) National Toxicology Program, Department of Health and Human Services, Nomination Profile, Triclosan [CAS3380-34-5], Supporting Information for Toxicological Evaluation Toxicology Program.
  2. CIR (Cosmetic Ingredient Review) (2010) Final Report Triclosan. Available from: http://www.cir-safety.org/sites/default/files/FR569.pdf/.
  3. SCCP (Scientific Committee on Consumer Products) (2009) OPINION ON Triclosan COLIPA $n^{\circ}$ P32. Available from:http://ec.europa.eu/health/ph_risk/committees/04_sccp/docs/sccp_o_166.pdf/.
  4. Dayan, A.D. (2007) Risk assessment of triclosan [Irgasan] in human breast milk. Food Chem. Toxicol., 45, 125-129. https://doi.org/10.1016/j.fct.2006.08.009
  5. Wolff, M., Teitelbaum, S., Windham, G., Pinney, S., Britton, J., Chelimo, C., Godbold, J., Biro, F., Kushi, L., Pfeiffer, C. and Calafat, A. (2007) Pilot study of urinary biomarkers of phytoestrogens, phthalates, and phenols in girls. Environ. Health Perspect., 115, 116-121. https://doi.org/10.1289/ehp.9488
  6. Calafat, A.M., Ye, X., Wong, L.Y., Reidy, J.A. and Needham, L.L. (2008) Urinary concentrations of triclosan in the U.S. population: 2003-2004. Environ. Health Perspect., 116, 303-307. https://doi.org/10.1289/ehp.10768
  7. Cullinan, M.P., Palmer, J.E., Carle, A.D., West, M.J., Westerman, B. and Seymour, G.J. (2015) The influence of a triclosan toothpaste on adverse events in patients with cardiovascular disease over 5-years. Sci. Total Environ., 508, 546-552. https://doi.org/10.1016/j.scitotenv.2014.11.052
  8. SCCS (Scientific Committee on Consumer Safety) (2011) Opinion On Triclosan, SCCS/1414/11.
  9. van Dijk, A. (1994) 14C-Triclosan: Absorption, Distribution Metabolism and Elimination after Single/Repeated Oral and Intravenous Administration to Hamsters (RCC Project 351707), RCC Umweltchemie AG, Itingen/BL, Switzerland.
  10. van Dijk, A. (1995) 14C-Triclosan: Absorption, Distribution, Metabolism and Elimination after Single/Repeated Oral and Intravenous Administration to Mice (RCC project no. 337781), RCC Umweltchemie AG, Itingen/BL, Switzerland.
  11. van Dijk, A. (1996) 14C-Triclosan: Absorption, Distribution and Excretion (ADE) after Single Oral and Repeated Oral Administration to Male Rats (RCC Project 341998), RCC Umweltchemie AG, Itingen/BL, Switzerland.
  12. Lin, Y.J. and Smith, N.L. (1990) Pharmacokinetics of Triclosan in Rats Following a Single Oral Administration, Colgate-Palmolive Company, Piscataway, New Jersey.
  13. Park, M., Kim, S., Kim, Y., Nam, D.J., Ryoo, J.H. and Lim, S. (2019) Relationship between personal care products usage and triclosan exposure: the second Korean National Environmental Health Survey (KoNEHS 2012-2014). Ann. Occup. Environ. Med., 31, 2. https://doi.org/10.1186/s40557-019-0283-y
  14. Crofton, K.M., Paul, K.B., Devito, M.J. and Hedge, J.M. (2007) Short-term in vivo exposure to the water contaminant triclosan: evidence for disruption of thyroxine. Environ. Toxicol. Pharmacol., 24, 194-197. https://doi.org/10.1016/j.etap.2007.04.008
  15. Paul, K.B., Hedge, J.M., Bansal, R., Zoeller, R.T., Peter, R., DeVito, M.J. and Crofton, K.M. (2012) Developmental triclosan exposure decreases maternal, fetal, and early neonatal thyroxine: a dynamic and kinetic evaluation of a putative mode-of-action. Toxicology, 300, 31-45. https://doi.org/10.1016/j.tox.2012.05.023
  16. Paul, K.B., Thompson, J.T., Simmons, S.O., Vanden Heuvel, J.P. and Crofton, K.M. (2013) Evidence for triclosaninduced activation of human and rodent xenobiotic nuclear receptors. Toxicol. In Vitro, 27, 2049-2060. https://doi.org/10.1016/j.tiv.2013.07.008
  17. Veldhoen, N., Skirrow, R.C., Osachoff, H., Wigmore, H., Clapson, D.J., Gunderson, M.P., Van Aggelen, G. and Helbing, C.C. (2006) The bactericidal agent triclosan modulates thyroid hormone-associated gene expression and disrupts postembryonic anuran development. Aquat. Toxicol., 80, 217-227. https://doi.org/10.1016/j.aquatox.2006.08.010
  18. Axelstad, M., Boberg, J., Vinggaard, A.M., Christiansen, S. and Hass, U. (2013) Triclosan exposure reduces thyroxine levels in pregnant and lactating rat dams and in directly exposed offspring. Food Chem. Toxicol., 59, 534-540. https://doi.org/10.1016/j.fct.2013.06.050
  19. Yueh, M.F. and Tukey, R.H. (2016) Triclosan: A widespread environmental toxicant with many biological effects. Annu. Rev. Pharmacol. Toxicol., 56, 251-272. https://doi.org/10.1146/annurev-pharmtox-010715-103417
  20. Health Canada (Environment and Climate Change Canada Health Canada) (2016) Assessment Report Triclosan, Chemical Abstracts Service Registry Number 3380-34-5. Available from: http://www.ec.gc.ca/ese-ees/65584A12-2B7D-4273-9F7A-38EDF916ECAF/EN%20FSAR%20Triclosan%20with%20ISBN.pdf/.
  21. Ley, C., Pischel, L. and Parsonnet, J. (2017) Triclosan and triclocarban exposure and thyroid function during pregnancy-a randomized intervention. Reprod. Toxicol., 74, 143-149. https://doi.org/10.1016/j.reprotox.2017.09.005
  22. Rodricks, J.V., Swenberg, J.A., Borzelleca, J.F., Maronpot, R.R. and Shipp, A.M. (2010) Triclosan: a critical review of the experimental data and development of margins of safety for consumer products. Crit. Rev. Toxicol., 40, 422-484. https://doi.org/10.3109/10408441003667514
  23. MFDS (The Ministry of Food and Drug Safety) (2017) Guideline for Risk Assessment of Cosmetic. Available from:http://www.nifds.go.kr/_custom/nifds/_common/board/download. jsp?attach_no=22848/.
  24. SCF (Scientific Committee on Food) (2000) Opinion of the Scientific Committee on Food on the 10th Additional List of Monomers and Additives for Food Contact Materials [adopted by the SCF on 2000 Jun 22]. Available from: http://europa.eu.int/comm/food/fs/sc/scf/out62_en.pdf/.
  25. EFSA (European Food Safety Authority) (2004) Opinion of the Scientific Panel on food additives, flavourings, processing aids and materials in contact with food. EFSA Journal, 37, 1-7. https://doi.org/10.2903/j.efsa.2004.1
  26. MFDS (The Ministry of Food and Drug Safety) (2017) Cosmetics Research Team, Risk Assessment of Cosmetics, Cheongju-Si: The National Institute of Food and Drug Safety Evaluation, pp. 151-172.
  27. ECHA (European Chemical Agency) (2019) Toxicological Information (Triclosan). Available from: https://echa.europa.eu/registration-dossier/-/registered-dossier/12675/1/.
  28. Burns, J. (1996) 14-Day Repeated Dose Dermal Study of Tricolsan in Mice. Triclosan Industry Alliance, Corning Hazleton Incorporated Laboratory. CHV 6718-101.
  29. Burns, J. (1997) 14-Day Repeated Dose Dermal Study of Tricolsan in CD-1 Mice, Triclosan Industry Alliance, Corning Hazleton Incorporated Laboratory.
  30. Burns, J. (1997) 14-Day Repeated Dose Dermal Study of Tricolsan in CD-1 Mice, Triclosan Industry Alliance, Corning Hazleton Incorporated Laboratory, CHV 6718-102. CHV 2763-100.
  31. Leutkemeier, H., Ullmann, L., Zak, F., Sachsse, K. and Shess, R. (1974) Irgasan DP 300 (Fat 80023/A) 21-Day Inhalation Study on the Rat. Ciba-Geigy Limited.
  32. Thevenaz, P. (1987) 28-Day Toxicity Studying Mice (Administration in Feed) with Special Reference To Histopathology, Final Report, Cibe-Geigy Limited. GU project number 864005.
  33. Trutter, J.A. (1993) 13-Week Subchronic Oral Toxicity Study of Triclosan in CD-1 Mice, HWA 483-287, Hazleton Washington Inc., Report No. CB 93/40.
  34. Litton Bionetics Inc. (1983) 90-Day Oral Toxicity Study in Rats with Fat 80-023/H (Litton Bionetics Inc.) Final Report, LBI Project No. 22188.
  35. NICNAS (National Industrial Chemicals Notification And Assessment Scheme) (2009) Priority Existing Chemical Assessment Report No. 30. Triclosan. Available from: http://www.nicnas.gov.au/__data/assets/pdf_file/0017/4391/PEC_30_Triclosan_Full_Report_PDF.pdf/.
  36. Schmid, H., Dotti, A., Keller, B., Kouchakji, G., Luetkemeir, H., Wilson, J., Biedermann, K. and Marbot, H. (1994) 13-Week Toxicity Study with Fat 80'023/R in the Hamster, Final Report, Ciba-Geigy Limited, RCC Project Number 356490.
  37. Leuschner, F., Leuschner, A., Schwerdtfeger, W. and Dontenwill, W. (1970) 90 Days Oral Toxicity Study in Beagle Dogs with CH 3565, Labortorium fur Pharmakologie und Toxikologie.
  38. Paterson, R.A. (1969) 13-Week Oral Toxicity Study in Rabbits. Irgasan DP 300, GP 41 353, Ciba-Geigy UK, Stamford Lodge, Wilmslow.
  39. Noel, P.R.B., Mawdesley-Thomas, L.E., Squires, P.F. and Street, A.E. (1969) Oral Toxicity Study in Baboons, Repeated Dosage for 4 and 13 Weeks. Irgasan DP 300, GP 41353, Huntingdon Research Centre, UK.
  40. Drake, J. (1975) 1 Year Oral Toxicity Study in Baboons with Compound Fat 80 023/A, Ciba-Geigy Limited, Jul 26.
  41. Auletta, C. (1995) An 18-Month Oral Oncogenicity study of Tricolsan in the Mouse via Dietary Administration, Pharmaco LSR, Study No. 93-2260.
  42. Yau, E. and Green, J. (1986) Fat 80'023 2-Year Oral Administration to Rats (MIN 833005), Ciba-Geigy Limited, Apr 28.
  43. Chambers, P. (1999) FAT 80′023/S Potential Tumorigenic and Chronic Toxicity Effects in Prolonged Dietary Administration to Hamsters, Huntingdon Life Sciences Ltd.
  44. Ena, L., Lim, J.S., Son, J.Y., Park, Y.J., Lee, Y.H., Kim, J.Y., Kwack, S.J., Lee, B.M., Ahn, M.Y. and Kim, H.S. (2018) Evaluation of subchronic exposure to triclosan on hepatorenal and reproductive toxicities in prepubertal male rats. J. Toxicol. Environ. Health A, 81, 421-431. https://doi.org/10.1080/15287394.2018.1451188
  45. Barkvoll, P. and Rolla, G. (1994) Triclosan protects the skin against dermatitis caused by sodium lauryl sulphate exposure. J. Clin. Periodontol., 21, 717-719. https://doi.org/10.1111/j.1600-051X.1994.tb00792.x
  46. Bendig, J.W. (1990) Surgical hand disinfection: comparison of 4% chlorhexidine detergent solution and 2% triclosan detergent solution. J. Hosp. Infect., 15, 143-148. https://doi.org/10.1016/0195-6701(90)90123-6
  47. Skaare, A., Kjaerheim, V., Barkvoll, P. and Rolla, G. (1997) Skin reactions and irritation potential of four commercial toothpastes. Acta. Odontol. Scand., 55, 133-136. https://doi.org/10.3109/00016359709115405
  48. Skaare, A.B., Rolla, G. and Barkvoll, P. (1997) The influence of triclosan, zinc or propylene glycol on oral mucosa exposed to sodium lauryl sulphate. Eur. J. Oral. Sci., 105, 527-533. https://doi.org/10.1111/j.1600-0722.1997.tb00240.x
  49. Sachsse, K. and Ullmann, L. (1975) Skin Irritation in the Rabbit after Single Application of FAT 80'023/A. Tox./Pathology PH 2.63, Project Siss 4719, Ciba-Geigy Ltd, CHBasel.
  50. Trimmer, G. (1994) 90-Day Subchronic Dermal Toxicity Study in the Rat with Satellite Group with Irgasan DP300 (MRD-92-399), Ciba-Geigy Limited, Exxon Biomedical Sciences, Inc, Toxicology Laboratory. Laboratory Project ID 139910B.
  51. Dorner, R.L. (1973) The Systemic Toxicological Effects of Three Bacteriostats Topically Applied to the Skin of Young Canines, L.R. E. Study # 301-002. Laboratory Research Enterprises, Inc., Kalamazoo, Michigan.
  52. Hazleton Labs, Inc. (1979) 90 Day Bathing of Newborn Rhesus Monkeys with Triclosan Soap Solution. Hazleton Laboratories America Inc., Vienna, Virginia.
  53. Baert, J.H., Veys, R.J., Ampe, K. and De Boever, J.A. (1996) The effect of sodium lauryl sulphate and triclosan on hamster cheek pouch mucosa. Int. J. Exp. Pathol., 77, 73-78. https://doi.org/10.1046/j.1365-2613.1996.00965.x
  54. Ullmann, L. (1980) Report on Eye Irritation in the Rabbit after Single Application of FAT 80'023/A, Final Report Project no. 801012, Experimental Toxicology, Ciba-Geigy Limited, Basle, Switzerland. Jul 8.
  55. Lyman, F.L. and Furia, T.E. (1968) Toxicology of 2,4,4'-trichloro-2'-hydroxyphenyl ether. IMS. Ind. Med. Surg., 37, 546.
  56. DeSalva, S.J., Kong, B.M. and Lin, Y.J. (1989) Triclosan: a safety profile. Am. J. Dent., 185-196.
  57. Mitchell, J.C., Adams, R.M., Glendenning, W.E., Fisher, A., Kanof, N., Larsen, W., Maibach, H.I., Rudner, E.J., Schnorr, W., Storrs, F. and Taylor, J.S. (1982) Results of standard patch tests with substances abandoned. Contact Derm., 8, 336-337. https://doi.org/10.1111/j.1600-0536.1982.tb04242.x
  58. Perrenoud, D., Bircher, A., Hunziker, T., Suter, H., Bruckner-Tuderman, L., Stager, J., Thurlimann, W., Schmid, P., Suard, A. and Hunziker, N. (1994) Frequency of sensitization to 13 common preservatives in Switzerland. Swiss Contact Dermatitis Research Group. Contact Derm., 30, 276-279. https://doi.org/10.1111/j.1600-0536.1994.tb00597.x
  59. Schnuch, A., Geier, J., Uter, W. and Frosch, P.J. (1998) Patch testing with preservatives, antimicrobials and industrial biocides. Results from a multicentre study. Br. J. Dermatol., 138, 467-476. https://doi.org/10.1046/j.1365-2133.1998.02126.x
  60. Savage, L., Rose, R. and Wilkinson, M. (2011) Airborne contact dermatitis to triclosan. Contact Derm., 65, 239-240. https://doi.org/10.1111/j.1600-0536.2011.01934.x
  61. Toxicological Resources (1974) Guinea Pig Buehler Dermal Sensitisation Study, Compound 1291, Project No. 2118-74, Toxicological Resources.
  62. Lachapelle, J.M. and Tennstedt, D. (1979) Low allergenicity of triclosan. Predictive testing in guinea pigs and in humans. Dermatologica, 158, 379-383. https://doi.org/10.1159/000250784
  63. Maurer, T., Thomann, P., Weirich, E.G. and Hess, R. (1979) Predictive evaluation in animals of the contact allergenic potential of medically important substances. II. Comparison of different methods of cutaneous sensitization with "weak" allergens. Contact Derm., 5, 1-10. https://doi.org/10.1111/j.1600-0536.1979.tb05528.x
  64. Wnorowski, G. (1994) Dermal Sensitisation Test-Buehler Method for Triclosan. Project Number 2635, Product Safety Labs, New Jersey.
  65. Morseth, S.L. (1988) Two-Generation Reproduction Study in Rats Fat 80'023 A. Ciba-Geigy Corporation, Hazleton Laboratories America, Inc., HLA Study No. 2386-100.
  66. Denning, H., Sliva, S. and Wilson, G. (1992) Triclosan:Effects on Pregnancy and Post Natal Development in Rats, Environmental Safety Laboratory, Unilever Research, Document Reference 92-105.
  67. Rodriguez, P.E. and Sanchez, M.S. (2010) Maternal exposure to triclosan impairs thyroid homeostasis and female pubertal development in Wistar rat offspring. J. Toxicol. Environ. Health A, 73, 1678-1688. https://doi.org/10.1080/15287394.2010.516241
  68. Kumar, V., Balomajumder, C. and Roy, P. (2008) Disruption of LH-induced testosterone biosynthesis in testicular Leydig cells by triclosan: probable mechanism of action. Toxicology, 250, 124-131. https://doi.org/10.1016/j.tox.2008.06.012
  69. Kumar, V., Chakraborty, A., Kural, M.R. and Roy, P. (2009) Alteration of testicular steroidogenesis and histopathology of reproductive system in male rats treated with triclosan. Reprod. Toxicol., 27, 177-185. https://doi.org/10.1016/j.reprotox.2008.12.002
  70. Stoker, T.E., Gibson, E.K. and Zorrilla, L.M. (2010) Triclosan exposure modulates estrogen-dependent responses in the female wistar rat. Toxicol. Sci., 117, 45-53. https://doi.org/10.1093/toxsci/kfq180
  71. Sandborgh-Englund, G., Adolfsson-Erici, M., Odham, G. and Ekstrand, J. (2006) Pharmacokinetics of triclosan following oral ingestion in humans. J. Toxicol. Environ. Health A., 69, 1861-1873. https://doi.org/10.1080/15287390600631706
  72. Wu, J., Yue, H. and Cai, Z. (2009) Investigation on metabolism and pharmacokinetics of triclosan in rat plasma by using UPLC-triple quadrupole MS. Se Pu, 27, 724-730.
  73. Christian. M. and Hoberman, A. (1992) Developmental Toxicity (Embryo-Fetal Toxicity and Teratogenic Potential) Study of C-P Sample No. 38326 Administered Orally Via the Diet to Cr1: CD1(ICR) BR Presumed Pregnant Mice. Argus Research Laboratories. Protocol number 403-010. Sponsor's Study number 92-001.
  74. Biodynamics Inc. (1992) A Range-Finding Study to Evaluate the Toxicity of Irgacare MP (C-P sample No: 8328) in the Pregnant Rat. Unpublished final test report 91-3654, Colgate-Palmolive study 91-013. Biodynamics Inc., New Jersey.
  75. Schroeder, R. and Daly, I. (1992) A Segment II Teratology Study in Rabbits with Irgacare MP (C-P sample no. 38328) Bio/Dynamics. Project no. 91-3666, Colgate-Palmolive study no. 91-006, Apr 16.
  76. Schroeder, R. and Daly, I. (1992) A Segment II Teratology Study in Rats with Irgacare MP (C-P Sample No. 38328) Bio/Dynamics. Project No. 91-3665, Colgate-Palmolive Study No. 91-005, Apr 16.
  77. Arni, P. and Muller, D. (1979) Intrasanguine Host-Mediated Assay with S. Typhimurium with FAT 80 023/A (Experiment no. 78/2803), Ciba-Geigy Ltd., Basel.
  78. Henderson, L.M., Proudlock, R.J., Haynes, P. and Meaking, K. (1988) Triclosan Mouse Micronucleus Test (HRC Study No. ULR 213/88492, Unilever Study No. KC 880168), Huntingdon Research Centre Ltd., Huntingdon.
  79. Riach, C.G. (1988) Triclosan: Assessment of Genotoxicity in an Unscheduled DNA Synthesis Assay Using Adult Rat Hepatatocyte Primary Cultures (IRI Report no. 4667, IRI Project no. 738388, Unilever Study No. KU 880258), Inveresk Research International, Musselburgh.
  80. Brooker, P.C., Gray, V.M. and Howell, A. (1988) Triclosan, Analysis of Metaphase Chromosomes Obtained from CHO Cells Cultured in Vitro (ULR 214/88731, Unilever Test No. KC 880171), Huntingdon Research Centre, Huntingdon.
  81. CCR Cytotest Cell Research (1991) Chromosome Aberration Assay in Bone Marrow Cells of the Rat wit FAT 80'023/Q (CCR Project No. 218305), CCR Cytotest Cell Research GMBH & Co., Ro$\ss$dorf.
  82. Strasser, F.F. and Muller, D. (1978) Point Mutation Assay with Mouse Lymphoma Cells I. In vitro test II. Host-mediated assay (Experiment No. 782305), Ciba-Geigy Ltd., CH-Basel.
  83. Russell, L.B. and Montgomery, C.S. (1980) Use of the mouse spot test to investigate the mutagenic potential of triclosan (Irgasan DP300). Mutat. Res., 79, 7-12. https://doi.org/10.1016/0165-1218(80)90142-1
  84. Strasser, F.F. and Muller, D. (1973) Chromosome Studies on Somatic Cells--GP 41 353 (Triclosan), Chinese Hamster, Ciba-Geigy Ltd., Basel.
  85. Langauer, M. and Muller, D. (1974) Nucleus Anomaly Test on Somatic Interphase Nuclei, GP 41 343 (Triclosan), Chinese Hamster. Ciba-Geigy Ltd., Basel.
  86. Magnusson, J. (1979) Mutagenic Effects of "Irgasan" on Drosophila Melanogaster (Brief report), Wallenberg Laboratory, Stockholm.
  87. Fritz, H. (1971) Dominant Lethal Study (Experiment No. 32710200), Ciba-Geigy Ltd, Basel.
  88. Hool, G., Strasser, F.F. and Muller, D. (1978) Chromosome Studies in Male Germinal Epithelium, FAT 80 023/A, Mouse (Experiment no. 78-2903), Ciba-Geigy Ltd., CH-Basel.
  89. ECHA (European Chemical Agency) (2019) Carcinogenicity (triclosan). Available from: https://echa.europa.eu/registration-dossier/-/registered-dossier/12675/7/8/?documentUUID=7f7a0e59-5295-4cfa-b2e2-d167a4fc2d8c/.
  90. Urbach, F. (1973) Phototoxicity Study in Mice, Pigs, and Humans, Irgasan DP-300, Temple University Skin and Cancer Hospital, Philadelphia, Apr 4.
  91. Bagley, D.M. and Lin, Y.J. (2000) Clinical evidence for the lack of triclosan accumulation from daily use in dentifrices. Am. J. Dent., 13, 148-152.
  92. Weatherly, L.M. and Gosse, J.A. (2017) Triclosan exposure, transformation, and human health effects. J. Toxicol. Environ. Health B. Crit Rev., 20, 447-469. https://doi.org/10.1080/10937404.2017.1399306
  93. US EPA (Environmental Protection Agency) (2008) Office of Prevention, Pesticides and Toxic Substances, Reregistration eligibility decision (RED) for Triclosan, List B, Case 2340.
  94. Black, J.G. and Howes, D. (1975) Percutaneous absorption of triclosan from toilet preparations. J. Soc. Cosmet. Chem., 26, 205-215.
  95. Chun Hong, H.S., Kurz, N.D., Wolf, T. and De Salva, S.J. (1976) Chemical Analysis of Hexachlorophene (HCP), Tribromsalan (TBS), Triclosan (DP-300), Triclocarban (TCC) and Cloflucarban (CF3) in Tissues, Blood and Urine of Animals and Humans, Meeting of the Society of Toxicology in Atlanta, Georgia.
  96. Moss, T., Howes, D. and Williams, F.M. (2000) Percutaneous penetration and dermal metabolism of triclosan (2,4,4'-Trichloro-2'hydroxydiphenyl Ether) Food Chem. Toxicol., 38, 316-370.
  97. EC (European Commission) (2003) Technical Guidance Document on Risk Assessment in Support of Commission Directive 93/67/EEC on Risk Assessment for New Notified Substances, Commission Regulation (EC) No 1488/94 on Risk Assessment for Existing Substances, Directive 98/8/EC of the European Parliament and of the Council concerning the Placing of Biocidal Products on the Market. Part 1. Luxembourg, Office for Official Publications of the European Communities.
  98. Park, G.H., Nam, C., Hong, S., Park, B., Kim, H., Lee, T., Kim, K., Lee, J.H. and Kim, M.H. (2018) Socioeconomic factors influencing cosmetic usage patterns. J. Expo. Sci. Environ. Epidemiol., 28, 242-250. https://doi.org/10.1038/jes.2017.20
  99. Thompson, T.A., Borman, C.H. and Goodblatt, R.S. (1975) Triclosan (Report 2): Concentration in Human Plasma and Urinary Excretion after Dermal Application of GP 41353 Patient Skin Prep, Drug Metabolism Report 1975-18.
  100. Stierlin, H. and Mucke, W. (1976) GP 41 353: Investigations of Percutaneous Absorption in the Rat and the Rabbit. Ciba-Geigy Limited.
  101. Park, I.S. and Lee, S.H. (2010) A study on the amount of toothpaste used among some college students. JKSDH, 10, 577-584.